These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Renal tubular acidosis in a patient with recurrent metabolic alkalosis. Hymes LC; Warshaw BL Pediatrics; 1983 Aug; 72(2):207-10. PubMed ID: 6408597 [TBL] [Abstract][Full Text] [Related]
24. Pathophysiology of primary distal renal tubular acidosis. Rodríguez-Soriano J; Vallo A; Castillo G; Oliveros R Int J Pediatr Nephrol; 1985; 6(1):71-8. PubMed ID: 3922906 [TBL] [Abstract][Full Text] [Related]
25. Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cyclosporine A associated side effect. Stahl RA; Kanz L; Maier B; Schollmeyer P Clin Nephrol; 1986 May; 25(5):245-8. PubMed ID: 3521998 [TBL] [Abstract][Full Text] [Related]
26. Severe hypertension, hyperkalemia, and renal tubular acidosis responding to dietary sodium restriction. Sanjad SA; Mansour FM; Hernandez RH; Hill LL Pediatrics; 1982 Mar; 69(3):317-24. PubMed ID: 7063287 [TBL] [Abstract][Full Text] [Related]
27. Hyperkalemia with mild ECF volume contraction: studies to provide a possible physiologic interpretation. Kamel KS; Halperin ML Clin Invest Med; 1994 Oct; 17(5):414-9. PubMed ID: 7867245 [TBL] [Abstract][Full Text] [Related]
28. Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II. Erdoğan G; Corapçioğlu D; Erdoğan MF; Hallioğlu J; Uysal AR J Endocrinol Invest; 1997 Dec; 20(11):681-4. PubMed ID: 9492109 [TBL] [Abstract][Full Text] [Related]
29. Nonazotemic hyperkalemia with renal and extrarenal defects in potassium transport: association with high levels of digoxin-like immunoreactive factor. Szylman P; Wolach B; Winaver J; Panett R; Cohen P; Shenkman L; Better OS J Lab Clin Med; 1990 Sep; 116(3):315-26. PubMed ID: 2205695 [TBL] [Abstract][Full Text] [Related]
32. Hyperkalemia and hypertension: is this a "chloride-shunt" disorder? Hirsch DJ Clin Invest Med; 1990 Dec; 13(6):360-6. PubMed ID: 2078915 [No Abstract] [Full Text] [Related]
33. Mechanisms of hyperkalemia in systemic lupus erythematosus. Lee FO; Quismorio FP; Troum OM; Anderson PW; Do YS; Hsueh WA Arch Intern Med; 1988 Feb; 148(2):397-401. PubMed ID: 3277563 [TBL] [Abstract][Full Text] [Related]
35. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression. Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134 [TBL] [Abstract][Full Text] [Related]
37. Hyperkalemia unresponsive to massive doses of aldosterone in a patient with renal tubular acidosis. Radó JP; Szende L; Szücs L Endokrinologie; 1976; 68(2):183-8. PubMed ID: 1009902 [TBL] [Abstract][Full Text] [Related]
38. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption. Schambelan M; Sebastian A; Rector FC Kidney Int; 1981 May; 19(5):716-27. PubMed ID: 7026872 [TBL] [Abstract][Full Text] [Related]